Mário Laço

526 total citations
15 papers, 437 citations indexed

About

Mário Laço is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Mário Laço has authored 15 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cellular and Molecular Neuroscience, 12 papers in Molecular Biology and 4 papers in Neurology. Recurrent topics in Mário Laço's work include Genetic Neurodegenerative Diseases (11 papers), Mitochondrial Function and Pathology (7 papers) and Neurological disorders and treatments (3 papers). Mário Laço is often cited by papers focused on Genetic Neurodegenerative Diseases (11 papers), Mitochondrial Function and Pathology (7 papers) and Neurological disorders and treatments (3 papers). Mário Laço collaborates with scholars based in Portugal, Canada and United States. Mário Laço's co-authors include A. Cristina Rego, Catarina R. Oliveira, Henry L. Paulson, Teresa Cunha‐Oliveira, Luana Naia, Tatiana R. Rosenstock, Michael R. Hayden, Sandra Almeida, Ana M. Oliveira and Catarina Carmo and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Mário Laço

15 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mário Laço Portugal 11 326 247 77 71 49 15 437
Catarina Carmo Portugal 5 283 0.9× 157 0.6× 63 0.8× 102 1.4× 57 1.2× 8 402
Carla Lopes Portugal 13 434 1.3× 238 1.0× 79 1.0× 109 1.5× 58 1.2× 20 585
Minna Kairisalo Finland 5 219 0.7× 152 0.6× 90 1.2× 120 1.7× 71 1.4× 6 452
Junbing Wu China 11 264 0.8× 135 0.5× 105 1.4× 68 1.0× 67 1.4× 14 512
Л. П. Долгачева Russia 9 197 0.6× 114 0.5× 129 1.7× 123 1.7× 48 1.0× 22 396
Joanne Clark United States 12 383 1.2× 170 0.7× 154 2.0× 155 2.2× 68 1.4× 14 592
Jessica D’Amico Italy 9 209 0.6× 109 0.4× 75 1.0× 70 1.0× 44 0.9× 14 334
Kanmin Mao China 9 192 0.6× 78 0.3× 129 1.7× 83 1.2× 140 2.9× 13 445
Sandra Franco-Iborra Spain 6 341 1.0× 134 0.5× 179 2.3× 121 1.7× 145 3.0× 8 553
Daniel Alvira Spain 13 243 0.7× 132 0.5× 83 1.1× 124 1.7× 62 1.3× 16 514

Countries citing papers authored by Mário Laço

Since Specialization
Citations

This map shows the geographic impact of Mário Laço's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mário Laço with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mário Laço more than expected).

Fields of papers citing papers by Mário Laço

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mário Laço. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mário Laço. The network helps show where Mário Laço may publish in the future.

Co-authorship network of co-authors of Mário Laço

This figure shows the co-authorship network connecting the top 25 collaborators of Mário Laço. A scholar is included among the top collaborators of Mário Laço based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mário Laço. Mário Laço is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Lopes, Carla, Ildete L. Ferreira, Sandra I. Mota, et al.. (2022). Mitochondrial and redox modifications in early stages of Huntington's disease. Redox Biology. 56. 102424–102424. 22 indexed citations
2.
Bauer, Christiane K., Denise Horn, Mário Laço, et al.. (2022). Clinically Relevant KCNQ1 Variants Causing KCNQ1-KCNE2 Gain-of-Function Affect the Ca2+ Sensitivity of the Channel. International Journal of Molecular Sciences. 23(17). 9690–9690. 2 indexed citations
3.
Laço, Mário, et al.. (2022). Progressive Generalized Dystonia‐Parkinsonism in a Child with Fumaric Aciduria. Movement Disorders Clinical Practice. 9(5). 707–709. 1 indexed citations
4.
Laço, Mário, et al.. (2020). A De Novo BSCL2 Gene S90L Mutation in a Progressive Tetraparesis with Urinary Dysfunction and Corpus Callosum Involvement. Journal of Pediatric Genetics. 10(3). 253–258. 1 indexed citations
5.
Castelhano, João, José Sereno, S.I. Gonçalves, et al.. (2018). A whole brain longitudinal study in the YAC128 mouse model of Huntington’s disease shows distinct trajectories of neurochemical, structural connectivity and volumetric changes. Human Molecular Genetics. 27(12). 2125–2137. 27 indexed citations
6.
Perfeito, Rita, et al.. (2017). Expanded and Wild-type Ataxin-3 Modify the Redox Status of SH-SY5Y Cells Overexpressing α-Synuclein. Neurochemical Research. 42(5). 1430–1437. 7 indexed citations
7.
Naia, Luana, Tatiana R. Rosenstock, Ana M. Oliveira, et al.. (2016). Comparative Mitochondrial-Based Protective Effects of Resveratrol and Nicotinamide in Huntington’s Disease Models. Molecular Neurobiology. 54(7). 5385–5399. 109 indexed citations
8.
Naia, Luana, Ildete L. Ferreira, Teresa Cunha‐Oliveira, et al.. (2014). Activation of IGF-1 and Insulin Signaling Pathways Ameliorate Mitochondrial Function and Energy Metabolism in Huntington’s Disease Human Lymphoblasts. Molecular Neurobiology. 51(1). 331–348. 64 indexed citations
9.
Silva, Ana, Sandra Almeida, Mário Laço, et al.. (2013). Mitochondrial respiratory chain complex activity and bioenergetic alterations in human platelets derived from pre-symptomatic and symptomatic Huntington's disease carriers. Mitochondrion. 13(6). 801–809. 38 indexed citations
10.
Laço, Mário, Luísa Cortes, Sue M. Travis, Henry L. Paulson, & A. Cristina Rego. (2012). Valosin-Containing Protein (VCP/p97) Is an Activator of Wild-Type Ataxin-3. PLoS ONE. 7(9). e43563–e43563. 21 indexed citations
11.
Laço, Mário, Catarina R. Oliveira, Henry L. Paulson, & A. Cristina Rego. (2011). Compromised mitochondrial complex II in models of Machado–Joseph disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1822(2). 139–149. 41 indexed citations
12.
Almeida, Sandra, Teresa Cunha‐Oliveira, Mário Laço, Catarina R. Oliveira, & A. Cristina Rego. (2009). Dysregulation of CREB Activation and Histone Acetylation in 3-Nitropropionic Acid-Treated Cortical Neurons: Prevention by BDNF and NGF. Neurotoxicity Research. 17(4). 399–405. 15 indexed citations
13.
Almeida, Sandra, Mário Laço, Teresa Cunha‐Oliveira, Catarina R. Oliveira, & A. Cristina Rego. (2009). BDNF regulates BIM expression levels in 3-nitropropionic acid-treated cortical neurons. Neurobiology of Disease. 35(3). 448–456. 32 indexed citations
14.
Todi, Sokol V., Mário Laço, Brett J Winborn, et al.. (2007). Cellular Turnover of the Polyglutamine Disease Protein Ataxin-3 Is Regulated by Its Catalytic Activity. Journal of Biological Chemistry. 282(40). 29348–29358. 43 indexed citations
15.
Domingues, António Miguel de Jesus, Teresa Cunha‐Oliveira, Mário Laço, et al.. (2006). Expression of NR1/NR2B N‐Methyl‐d‐Aspartate Receptors Enhances Heroin Toxicity in HEK293 Cells. Annals of the New York Academy of Sciences. 1074(1). 458–465. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026